Brain damage in neonatal mice following monosodium glutamate administration: possible involvement of hypernatremia and hyperosmolality.
D000679:Amygdala / Q000473:pathology; D000818:Animals; D000831:Animals, Newborn; D001925:Brain Damage, Chronic / Q000139:chemically induced* / Q000209:etiology / Q000473:pathology; D002421:Caudate Nucleus / Q000473:pathology; D002531:Cerebellum / Q000473:pathology; D002540:Cerebral Cortex / Q000473:pathology; D004195:Disease Models, Animal; D005971:Glutamates / Q000633:toxicity*; D006624:Hippocampus / Q000473:pathology; D006955:Hypernatremia / Q000150:complications*; D007031:Hypothalamus / Q000473:pathology; D008636:Mesencephalon / Q000473:pathology; D051379:Mice; D008813:Mice, Inbred ICR; D008854:Microscopy, Electron; D009830:Olfactory Bulb / Q000473:pathology; D009994:Osmolar Concentration; D011699:Putamen / Q000473:pathology; D012970:Sodium Glutamate / Q000633:toxicity*; D003336:Tectum Mesencephali / Q000473:pathology; D013788:Thalamus / Q000473:pathology
D005971:Glutamates; D012970:Sodium Glutamate